266 related articles for article (PubMed ID: 38317930)
1. MiRNA in cervical cancer: Diagnosis to therapy: Systematic review.
Endale HT; Mariye YF; Negash HK; Hassen FS; Asrat WB; Mengstie TA; Tesfaye W
Heliyon; 2024 Feb; 10(3):e24398. PubMed ID: 38317930
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.
Mitra T; Elangovan S
Mol Cell Biochem; 2021 Dec; 476(12):4363-4385. PubMed ID: 34453645
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications.
Castro-Oropeza R; Piña-Sánchez P
Front Genet; 2022; 13():886613. PubMed ID: 35774512
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as markers of progression in cervical cancer: a systematic review.
Pardini B; De Maria D; Francavilla A; Di Gaetano C; Ronco G; Naccarati A
BMC Cancer; 2018 Jun; 18(1):696. PubMed ID: 29945565
[TBL] [Abstract][Full Text] [Related]
5. The mechanisms and diagnostic potential of lncRNAs, miRNAs, and their related signaling pathways in cervical cancer.
Xu Y; Sun Y; Song X; Ren J
Front Cell Dev Biol; 2023; 11():1170059. PubMed ID: 37215076
[TBL] [Abstract][Full Text] [Related]
6. miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay.
Doghish AS; Ali MA; Elyan SS; Elrebehy MA; Mohamed HH; Mansour RM; Elgohary A; Ghanem A; Faraag AHI; Abdelmaksoud NM; Moustafa HAM
Pathol Res Pract; 2023 Apr; 244():154386. PubMed ID: 36868096
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
Nascimento NPG; Gally TB; Borges GF; Campos LCG; Kaneto CM
BMC Cancer; 2022 Aug; 22(1):862. PubMed ID: 35933332
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of miRNA-10a-5p promotes tumor progression in cervical cancer by suppressing UBE2I signaling.
Gu Y; Feng X; Jin Y; Liu Y; Zeng L; Zhou D; Feng Y
J Obstet Gynaecol; 2023 Dec; 43(1):2171283. PubMed ID: 36744815
[TBL] [Abstract][Full Text] [Related]
9. The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer.
Hasanzadeh M; Movahedi M; Rejali M; Maleki F; Moetamani-Ahmadi M; Seifi S; Hosseini Z; Khazaei M; Amerizadeh F; Ferns GA; Rezayi M; Avan A
J Cell Physiol; 2019 Feb; 234(2):1289-1294. PubMed ID: 30191988
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes.
Weng SL; Huang KY; Weng JT; Hung FY; Chang TH; Lee TY
Brief Bioinform; 2018 Nov; 19(6):1102-1114. PubMed ID: 28531277
[TBL] [Abstract][Full Text] [Related]
11. From squamous intraepithelial lesions to cervical cancer: Circulating microRNAs as potential biomarkers in cervical carcinogenesis.
Berti FCB; Salviano-Silva A; Beckert HC; de Oliveira KB; Cipolla GA; Malheiros D
Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188306. PubMed ID: 31398380
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
Xin X; Jia-Yin Y; Jun-Yang H; Rui W; Xiong-Ri K; Long-Rui D; Liu J; Jue-Yu Z
Comput Biol Med; 2023 Jun; 159():106943. PubMed ID: 37099974
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies.
Bhattacharjee R; Das SS; Biswal SS; Nath A; Das D; Basu A; Malik S; Kumar L; Kar S; Singh SK; Upadhye VJ; Iqbal D; Almojam S; Roychoudhury S; Ojha S; Ruokolainen J; Jha NK; Kesari KK
Crit Rev Oncol Hematol; 2022 Jun; 174():103675. PubMed ID: 35381343
[TBL] [Abstract][Full Text] [Related]
14. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
15. Role of miRNAs in cervical cancer: A comprehensive novel approach from pathogenesis to therapy.
Abbas M; Mehdi A; Khan FH; Verma S; Ahmad A; Khatoon F; Raza ST; Afreen S; Glynn SA; Mahdi F
J Gynecol Obstet Hum Reprod; 2021 Nov; 50(9):102159. PubMed ID: 33965650
[TBL] [Abstract][Full Text] [Related]
16. A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.
Sharma G; Dua P; Agarwal SM
Curr Genomics; 2014 Aug; 15(4):310-23. PubMed ID: 25132800
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health.
Sammarco ML; Tamburro M; Pulliero A; Izzotti A; Ripabelli G
Microrna; 2020; 9(3):174-186. PubMed ID: 31738147
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Long Non-coding and Circular RNAs in Human Papillomavirus-Mediated Cervical Cancer.
Wang H; Zhao Y; Chen M; Cui J
Front Microbiol; 2017; 8():1720. PubMed ID: 28970820
[TBL] [Abstract][Full Text] [Related]
19. Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
Nair VB; Manasa VG; Sinto MS; Jayasree K; James FV; Kannan S
Int J Gynecol Cancer; 2018 Mar; 28(3):553-562. PubMed ID: 29466255
[TBL] [Abstract][Full Text] [Related]
20. Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.
Van Kriekinge G; Castellsagué X; Cibula D; Demarteau N
Vaccine; 2014 Feb; 32(6):733-9. PubMed ID: 24291200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
